| Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. | |
| | |
MedLine Citation:
|
PMID: 18276738 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Recommendations and/or guidelines represent a popular way of integrating evidence-based medicine into clinical practice. The 3E Initiatives is a multi-national effort to develop recommendations for the management of rheumatic diseases, which involves a large number of experts combined with practising rheumatologists addressing specific questions relevant to clinical practice. METHODS: Ten countries participated in three rounds of discussions and votes concerning the management of AS. A set of nine questions was formulated in the domains of diagnosis, monitoring and treatment, after a Delphi procedure. A literature search in MedLine was conducted. Predefined outcome parameters for the domains of diagnosis, monitoring and treatment were assessed. The evidence to support each proposition was evaluated and scored. After discussion and votes, the final recommendations were presented using brief statements by each national group, following which the final international recommendations were formulated. RESULTS: A total of 2699 papers were found and 467 were selected for analysis. Twelve key recommendations were developed: three in the domain of diagnosis addressing general diagnostic considerations, early AS diagnosis and general practitioners' referral recommendations; three concerning monitoring of AS disease activity, severity and prognosis; six concerning pharmacological treatment (except biologics): non-steroidal anti-inflammatory drugs/COX-II inhibitors, bisphosphonates and treatment of enthesitis. The compiled agreement among experts ranged from 72% to 93%. CONCLUSION: Recommendations for the management of AS were developed using an evidence-based approach followed by expert/physician consensus with high level of agreement. Involvement of a larger and more representative group of rheumatologists may improve their dissemination and implementation in daily clinical practice. |
| | |
Authors:
|
P I Sidiropoulos; G Hatemi; I-H Song; J Avouac; E Collantes; V Hamuryudan; M Herold; T K Kvien; H Mielants; J M Mendoza; I Olivieri; M Østergaard; L Schachna; J Sieper; D T Boumpas; M Dougados |
Related Documents
:
|
21805758 - Management of patients with interstitial cystitis: a case study. 19107728 - Using evidence to inform clinical practice shortly after traumatic events. 3340898 - Western cape local authority compliance with tuberculosis policy, 1984. 11714118 - Knowledge, attitudes and practices regarding evidence-based medicine and outcome assess... 23354808 - Patient perspectives on type 2 diabetes and medicine use during ramadan among pakistani... 22428708 - Collaborative relationships and dialogic conversations: ideas for a relationally respon... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Rheumatology (Oxford, England) Volume: 47 ISSN: 1462-0332 ISO Abbreviation: Rheumatology (Oxford) Publication Date: 2008 Mar |
Date Detail:
|
Created Date: 2008-02-15 Completed Date: 2008-03-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883501 Medline TA: Rheumatology (Oxford) Country: England |
Other Details:
|
Languages: eng Pagination: 355-61 Citation Subset: AIM; IM |
Affiliation:
|
Department of Internal Medicine, Division of Rheumatology, Clinical Immunology and Allergy, University of Crete, Medical School, Voutes 71500, Heraklion, Greece. sidiropp@med.uoc.gr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Inflammatory Agents, Non-Steroidal
/
therapeutic use* Cyclooxygenase 2 Inhibitors / therapeutic use* Disease Progression Dose-Response Relationship, Drug Drug Administration Schedule Drug Therapy, Combination Evidence-Based Medicine / standards* Female Follow-Up Studies Humans International Cooperation Male Monitoring, Physiologic / methods Practice Guidelines as Topic* Randomized Controlled Trials as Topic Spondylitis, Ankylosing / diagnosis*, drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Cyclooxygenase 2 Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synov...
Next Document: Stress, coping strategies and social support in patients with primary Sjögren's syndrome prior to d...